VildMedVin Kolding ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  5.8% 5.8% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 8.4% 5.1%  
Credit score (0-100)  0 0 0 29 37  
Credit rating  N/A N/A N/A B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 140 850  
EBITDA  0.0 0.0 0.0 -31.9 153  
EBIT  0.0 0.0 0.0 -31.9 153  
Pre-tax profit (PTP)  0.0 0.0 0.0 -42.2 147.0  
Net earnings  0.0 0.0 0.0 -34.1 112.3  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -42.2 147  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 5.9 118  
Interest-bearing liabilities  0.0 0.0 0.0 430 132  
Balance sheet total (assets)  0.0 0.0 0.0 780 970  

Net Debt  0.0 0.0 0.0 -164 -567  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 140 850  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 509.2%  
Employees  0 0 0 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 780 970  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 24.4%  
Added value  0.0 0.0 0.0 -31.9 153.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -22.9% 18.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -4.1% 17.5%  
ROI %  0.0% 0.0% 0.0% -6.4% 36.7%  
ROE %  0.0% 0.0% 0.0% -578.1% 181.0%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 0.8% 12.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 512.6% -369.4%  
Gearing %  0.0% 0.0% 0.0% 7,283.2% 111.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 4.8% 2.3%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.9 1.1  
Current Ratio  0.0 0.0 0.0 0.9 1.1  
Cash and cash equivalent  0.0 0.0 0.0 593.3 698.2  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -70.6 45.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -16 77  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -16 77  
EBIT / employee  0 0 0 -16 77  
Net earnings / employee  0 0 0 -17 56